LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 8.76 | 27.76 | 888 | 401 | 2.2137 | 1.4581 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 8.76 | 27.76 | 24 | 401 | 0.0598 | -0.0371 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 8.76 | 27.76 | 768 | 401 | 1.9145 | 1.3672 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.46 | 27.76 | 11 | 438 | 0.0251 | -0.2074 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.46 | 27.76 | 931 | 438 | 2.1225 | 1.4161 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.46 | 27.76 | 37 | 438 | 0.0844 | 0.0748 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.46 | 27.76 | 629 | 438 | 1.4340 | 1.1895 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 12.17 | 27.76 | 73 | 489 | 0.1493 | 0.2632 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 12.17 | 27.76 | 1023 | 489 | 2.0917 | 1.3904 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 12.17 | 27.76 | 46 | 489 | 0.0941 | 0.1298 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 12.17 | 27.76 | 852 | 489 | 1.7421 | 1.2870 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 13.87 | 27.76 | 408 | 604 | 0.6747 | 0.8306 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 13.87 | 27.76 | 1088 | 604 | 1.7992 | 1.2825 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 13.87 | 27.76 | 56 | 604 | 0.0926 | 0.1710 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 13.87 | 27.76 | 667 | 604 | 1.1030 | 1.0446 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 15.58 | 27.76 | 749 | 685 | 1.0925 | 1.0386 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 15.58 | 27.76 | 1118 | 685 | 1.6308 | 1.2230 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 15.58 | 27.76 | 70 | 685 | 0.1021 | 0.2213 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 15.58 | 27.76 | 1247 | 685 | 1.8189 | 1.2761 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 17.28 | 27.76 | 1076 | 838 | 1.2829 | 1.1039 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 17.28 | 27.76 | 1202 | 838 | 1.4331 | 1.1519 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 17.28 | 27.76 | 87 | 838 | 0.1037 | 0.2615 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 17.28 | 27.76 | 917 | 838 | 1.0933 | 1.0366 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 18.98 | 27.76 | 1118 | 941 | 1.1879 | 1.0689 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 18.98 | 27.76 | 1199 | 941 | 1.2740 | 1.0976 | MN20160318_Q01 | I06 |